1-866-991-6956 • marketing@artaira.com
ARTAIRA® Arterial Compression Device: Now Covered by Medicare
Effective, High-Pressure Sequential Compression for Improved Blood Flow
FDA-cleared for use in patients with Peripheral Arterial Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI), the ARTAIRA® device delivers high-pressure intermittent pneumatic compression (IPC) therapy designed to enhance lower limb circulation.
NOTE: Medicare is now paying for the ARTAIRA® arterial compression device under HCPCS Code E0675.
Ideal Candidates for ARTAIRA®
- Patients with Chronic Limb-Threatening Ischemia (CLTI) or Critical Limb Ischemia
- Individuals awaiting surgery or recovering from vascular procedures
- Those who are not candidates for surgery due to high risk or previous failure
- Patients experiencing intermittent claudication (walking pain), rest pain, diabetic or arterial foot ulcers, slow-healing wounds, or gangrene
Patient Benefits
- Walk longer distances without pain
- Improve Ankle-Brachial Index (ABI) and overall blood circulation
- Heal wounds and ulcers more quickly
- Experience less rest pain
Device Features
- One-Touch Operation
- Large Color LCD Display
- Lightweight & Portable with Handle
- Pause/Resume Button
- Built-in Usage Tracker
- Durable, Easy-to-Apply Garments (One size fits all)
Get Started Today
Want to see how the ARTAIRA® device can help your patients with PAD, CLTI, or non-healing wounds? Complete the form below to connect with our clinical team. We’ll provide information, reimbursement support, or schedule a product demo.
"*" indicates required fields
IPC pumps have been shown to increase arterial inflow, walking distance, and circulation over decades of clinical use. The ARTAIRA device is an excellent option for non-surgical patients and as an adjunctive therapy post-procedure.
